Exposure Keratopathy: An Idiopathic Lagophthalmos Case Report

被引:1
作者
Alhoutan, Khalid [1 ]
Alarfaj, Khalid [2 ]
机构
[1] Ad Diriyah Hosp, Ophthalmol, Ad Diriyah, Saudi Arabia
[2] King Fahd Univ Hosp, Ophthalmol, Dammam, Saudi Arabia
关键词
anterior segment; lagophthalmos; keratitis; exposure keratopathy; cornea; EYE CARE; PROSE TREATMENT; MANAGEMENT; DISORDERS;
D O I
10.7759/cureus.18945
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exposure keratopathy refers to corneal damage that results primarily from prolonged exposure of the ocular surface to the outside environment. Herein, we describe a case of exposure keratopathy with bilateral idiopathic lagophthalmos and discuss factors pertaining to prompt diagnosis and treatment. A 21-year-old woman presented with bilateral nocturnal lagophthalmos, blurred vision, and whitish spots in both eyes. She had no remarkable history of medication use, trauma, surgery, cranial nerve abnormality, critical illness, or other ocular problems. Examination revealed bilateral lagophthalmos, good Bell's phenomenon, bilateral inferior corneal scars, and vision loss. Laboratory results were normal; there was an absence of proptosis, and no epithelial defects were apparent. Based on these findings, she was diagnosed with exposure keratopathy resulting from idiopathic bilateral lagophthalmos and treated with lubricants. This was a rare case of exposure keratopathy with bilateral lagophthalmos of idiopathic origin, and a challenging one, which prompted the researchers to formulate an appropriate treatment plan.
引用
收藏
页数:4
相关论文
共 50 条
[31]   Case Report: Idiopathic Sclerosing Orbital Inflammation [J].
Groth, Jane A. Bachman ;
Harris, Gerald J. .
OPTOMETRY AND VISION SCIENCE, 2021, 98 (04) :409-417
[32]   Effective management of exposure keratopathy developed in intensive care units: The impact of an evidence based eye care education programme [J].
Demirel, Soner ;
Cumurcu, Tongabay ;
Firat, Penpegul ;
Aydogan, Mustafa Said ;
Doganay, Selim .
INTENSIVE AND CRITICAL CARE NURSING, 2014, 30 (01) :38-44
[33]   Immunotactoid keratopathy: A clinicopathologic case report and a review of reports of corneal involvement in systemic paraproteinemias [J].
Garibaldi, DC ;
Gottsch, J ;
de la Cruz, Z ;
Haas, M ;
Green, WR .
SURVEY OF OPHTHALMOLOGY, 2005, 50 (01) :61-80
[34]   Ripasudil eyedrops ameliorated bullous keratopathy complicated with cytomegalovirus corneal endotheliitis: a case report [J].
Yoshida, Masaaki ;
Yokokura, Shunji ;
Hariya, Takehiro ;
Kobayashi, Wataru ;
Hashimoto, Kazuki ;
Nakazawa, Toru .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (01) :207-210
[35]   Diagnosis of juvenile idiopathic arthritis with asymptomatic involvement of the temporomandibular joint: A case report [J].
Ferrazzo, Kivia Linhares ;
Thomas, Alexander ;
Danesi, Cristiane Cademartori ;
Marquezan, Mariana ;
Ferrazzo, Vilmar Antonio .
SPECIAL CARE IN DENTISTRY, 2023, 43 (02) :267-275
[36]   Incidence and risk factor evaluation of exposure keratopathy in critically ill patients: A cohort study [J].
Kuruvilla, Shilpa ;
Peter, Jayanthi ;
David, Sarada ;
Premkumar, Prasanna Samuel ;
Ramakrishna, Kartik ;
Thomas, Lovely ;
Vedakumar, Manuel ;
Peter, John Victor .
JOURNAL OF CRITICAL CARE, 2015, 30 (02) :400-404
[37]   Exposure keratopathy following phacoemulsification under local anaesthesia [J].
Dinakaran, S .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2002, 12 (04) :331-332
[38]   A novel agent for myeloma causing toxic keratopathy, belantamab mafodotin: a case report and literature review [J].
Kurt, Rengin Aslihan ;
Goren, Deniz ;
Karadeniz, Sehnaz ;
Arat, Mutlu ;
Sahin, Afsun .
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2024, 87 (04)
[39]   Idiopathic granulomatous mastitis with extramammary manifestations: a case report [J].
Hamsho, Suaad ;
Alaswad, Mohammed ;
Alsmodi, Hasan ;
Sleiay, Mouhammed ;
Hoha, Ghofran ;
Alcheikh, Salwa .
ANNALS OF MEDICINE AND SURGERY, 2023, 85 (12) :6192-6195
[40]   Idiopathic Hemifacial Spasm Responsive to Zonisamide: A Case Report [J].
Siniscalchi, Antonio ;
Gallelli, Luca ;
Palleria, Caterina ;
De Sarro, Giovambattista .
CLINICAL NEUROPHARMACOLOGY, 2009, 32 (04) :230-231